New screener: ๐Ÿฆ Banks ranked by their 5 year credit default swap [external link]
Amgen
AMGN
#93
Rank
$128.70 B
Marketcap
$241.03
Share price
1.07%
Change (1 day)
-0.21%
Change (1 year)

The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.

P/E ratio for Amgen (AMGN)

P/E ratio as of March 2023 (TTM): 19.8

According to Amgen's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 19.789. At the end of 2021 the company had a P/E ratio of 21.7.

P/E ratio history for Amgen from 2001 to 2022

PE ratio at the end of each year

Year P/E ratio Change
202121.717.02%
202018.6-0.31%
201918.621.35%
201815.3-76.8%
201766.1366.71%
201614.2-20.05%
201517.7-24.46%
201423.538.6%
201316.99.96%
201215.4

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
22.4 13.44%๐Ÿ‡บ๐Ÿ‡ธ USA
7.19-63.68%๐Ÿ‡บ๐Ÿ‡ธ USA
23.6 19.26%๐Ÿ‡บ๐Ÿ‡ธ USA
50.0 152.90%๐Ÿ‡บ๐Ÿ‡ธ USA
13.1-34.03%๐Ÿ‡บ๐Ÿ‡ธ USA
22.1 11.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-7.93-140.07%๐Ÿ‡บ๐Ÿ‡ธ USA
25.1 26.67%๐Ÿ‡บ๐Ÿ‡ธ USA
4.43-77.59%๐Ÿ‡ฌ๐Ÿ‡ง UK

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.